| Item Type | Name |
|
Concept
|
Cell Line, Transformed
|
|
Concept
|
Combined Modality Therapy
|
|
Concept
|
Cytotoxicity Tests, Immunologic
|
|
Concept
|
T-Lymphocytes, Helper-Inducer
|
|
Concept
|
Immune Tolerance
|
|
Concept
|
Mice, Transgenic
|
|
Concept
|
Neoplasm Transplantation
|
|
Concept
|
Time Factors
|
|
Concept
|
Tissue Donors
|
|
Concept
|
Tryptophan
|
|
Concept
|
Biomarkers, Tumor
|
|
Concept
|
Tumor Necrosis Factor-alpha
|
|
Concept
|
Transduction, Genetic
|
|
Concept
|
Transplantation, Heterologous
|
|
Concept
|
Hematopoietic Stem Cell Transplantation
|
|
Concept
|
Th1 Cells
|
|
Concept
|
Trans-Activators
|
|
Concept
|
Cell Culture Techniques
|
|
Concept
|
Reverse Transcriptase Polymerase Chain Reaction
|
|
Concept
|
Tumor Cells, Cultured
|
|
Concept
|
Tyrosine
|
|
Concept
|
CD4-Positive T-Lymphocytes
|
|
Concept
|
Lymphocytes, Tumor-Infiltrating
|
|
Concept
|
T-Lymphocyte Subsets
|
|
Concept
|
T-Cell Antigen Receptor Specificity
|
|
Concept
|
Protein Structure, Tertiary
|
|
Concept
|
Receptors, Antigen, T-Cell, alpha-beta
|
|
Concept
|
Treatment Outcome
|
|
Concept
|
CD8-Positive T-Lymphocytes
|
|
Concept
|
Th2 Cells
|
|
Concept
|
Genes, T-Cell Receptor
|
|
Concept
|
Epitopes, T-Lymphocyte
|
|
Concept
|
Tumor Burden
|
|
Concept
|
Adoptive Transfer
|
|
Concept
|
Molecular Targeted Therapy
|
|
Concept
|
Cell Engineering
|
|
Concept
|
T-Lymphocytes, Cytotoxic
|
|
Concept
|
Transfection
|
|
Concept
|
Genetic Therapy
|
|
Concept
|
Neoadjuvant Therapy
|
|
Concept
|
T-Box Domain Proteins
|
|
Concept
|
T-Lymphocytes, Regulatory
|
|
Concept
|
STAT1 Transcription Factor
|
|
Concept
|
Transcriptome
|
|
Concept
|
Tumor Microenvironment
|
|
Concept
|
Lectins, C-Type
|
|
Concept
|
Cell Line, Tumor
|
|
Concept
|
STAT6 Transcription Factor
|
|
Concept
|
Ikaros Transcription Factor
|
|
Concept
|
T Cell Transcription Factor 1
|
|
Concept
|
Forkhead Transcription Factors
|
|
Concept
|
Clinical Trials as Topic
|
|
Concept
|
Receptors, Antigen, T-Cell
|
|
Concept
|
T-Lymphocytes
|
|
Concept
|
Transplantation, Homologous
|
|
Concept
|
Signal Transduction
|
|
Concept
|
Tumor Suppressor Protein p53
|
|
Concept
|
Coculture Techniques
|
|
Concept
|
Laboratory Proficiency Testing
|
|
Academic Article
|
Potentiation of tumor eradication by adoptive immunotherapy with T-cell receptor gene-transduced T-helper type 1 cells.
|
|
Academic Article
|
An efficient method to prepare T cell receptor gene-transduced cytotoxic T lymphocytes type 1 applicable to tumor gene cell-therapy.
|
|
Academic Article
|
Non-redundant requirement for CXCR3 signalling during tumoricidal T-cell trafficking across tumour vascular checkpoints.
|
|
Academic Article
|
Immunomodulatory action of the DNA methyltransferase inhibitor SGI-110 in epithelial ovarian cancer cells and xenografts.
|
|
Academic Article
|
Clonality and antigen-specific responses shape the prognostic effects of tumor-infiltrating T cells in ovarian cancer.
|
|
Academic Article
|
Efficient identification of neoantigen-specific T-cell responses in advanced human ovarian cancer.
|
|
Academic Article
|
IFN-gamma-induced SOCS-1 regulates STAT6-dependent eotaxin production triggered by IL-4 and TNF-alpha.
|
|
Academic Article
|
Expression and immune responses to MAGE antigens predict survival in epithelial ovarian cancer.
|
|
Academic Article
|
Immunomodulatory action of SGI-110, a hypomethylating agent, in acute myeloid leukemia cells and xenografts.
|
|
Academic Article
|
NKT cells act as regulatory cells rather than killer cells during activation of NK cell-mediated cytotoxicity by alpha-galactosylceramide in vivo.
|
|
Academic Article
|
Immunomodulating effect of vitamin D3 derivatives on type-1 cellular immunity.
|
|
Academic Article
|
A Pilot Study of Stereotactic Body Radiation Therapy Combined with Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma.
|
|
Academic Article
|
Direct tumor recognition by a human CD4(+) T-cell subset potently mediates tumor growth inhibition and orchestrates anti-tumor immune responses.
|
|
Academic Article
|
WHSC1/NSD2 regulates immune infiltration in prostate cancer.
|
|
Academic Article
|
Split T cell tolerance against a self/tumor antigen: spontaneous CD4+ but not CD8+ T cell responses against p53 in cancer patients and healthy donors.
|
|
Academic Article
|
A rare population of tumor antigen-specific CD4+CD8+ double-positive aß T lymphocytes uniquely provide CD8-independent TCR genes for engineering therapeutic T cells.
|
|
Academic Article
|
Critical role of the Th1/Tc1 circuit for the generation of tumor-specific CTL during tumor eradication in vivo by Th1-cell therapy.
|
|
Academic Article
|
Immunosteroid as a regulator for Th1/Th2 balance: its possible role in autoimmune diseases.
|
|
Academic Article
|
Generation and regulation of human CD4+ IL-17-producing T cells in ovarian cancer.
|
|
Academic Article
|
LAG3 and PD1 co-inhibitory molecules collaborate to limit CD8+ T cell signaling and dampen antitumor immunity in a murine ovarian cancer model.
|
|
Academic Article
|
STAT6-mediated signaling in Th2-dependent allergic asthma: critical role for the development of eosinophilia, airway hyper-responsiveness and mucus hypersecretion, distinct from its role in Th2 differentiation.
|
|
Academic Article
|
Generation of tumor-specific, HLA class I-restricted human Th1 and Tc1 cells by cell engineering with tumor peptide-specific T-cell receptor genes.
|
|
Academic Article
|
Heat shock protein 90-mediated peptide-selective presentation of cytosolic tumor antigen for direct recognition of tumors by CD4(+) T cells.
|
|
Academic Article
|
HLA superfamily assignment is a predictor of immune response to cancer testis antigens and survival in ovarian cancer.
|
|
Academic Article
|
Rapid Construction of Antitumor T-cell Receptor Vectors from Frozen Tumors for Engineered T-cell Therapy.
|
|
Academic Article
|
Vaccination with an NY-ESO-1 peptide of HLA class I/II specificities induces integrated humoral and T cell responses in ovarian cancer.
|
|
Academic Article
|
Interleukin 2-mediated conversion of ovarian cancer-associated CD4+ regulatory T cells into proinflammatory interleukin 17-producing helper T cells.
|
|
Academic Article
|
Induction of cancer testis antigen expression in circulating acute myeloid leukemia blasts following hypomethylating agent monotherapy.
|
|
Academic Article
|
1alpha,25-Dihydroxyvitamin D3 downmodulates the functional differentiation of Th1 cytokine-conditioned bone marrow-derived dendritic cells beneficial for cytotoxic T lymphocyte generation.
|
|
Academic Article
|
Recognition of naturally processed and ovarian cancer reactive CD8+ T cell epitopes within a promiscuous HLA class II T-helper region of NY-ESO-1.
|
|
Academic Article
|
Sublethal Radiation Affects Antigen Processing and Presentation Genes to Enhance Immunogenicity of Cancer Cells.
|
|
Academic Article
|
NY-ESO-1 Vaccination in Combination with Decitabine Induces Antigen-Specific T-lymphocyte Responses in Patients with Myelodysplastic Syndrome.
|
|
Academic Article
|
Efficacy of levo-1-methyl tryptophan and dextro-1-methyl tryptophan in reversing indoleamine-2,3-dioxygenase-mediated arrest of T-cell proliferation in human epithelial ovarian cancer.
|
|
Academic Article
|
An Immunosuppressive Effect of Melanoma-derived Exosomes on NY-ESO-1 Antigen-specific Human CD8+ T Cells is Dependent on IL-10 and Independent of BRAFV600E Mutation in Melanoma Cell Lines.
|
|
Academic Article
|
Epigenetic potentiation of NY-ESO-1 vaccine therapy in human ovarian cancer.
|
|
Academic Article
|
Antibody-targeted NY-ESO-1 to mannose receptor or DEC-205 in vitro elicits dual human CD8+ and CD4+ T cell responses with broad antigen specificity.
|
|
Academic Article
|
Nonclassical antigen-processing pathways are required for MHC class II-restricted direct tumor recognition by NY-ESO-1-specific CD4(+) T cells.
|
|
Academic Article
|
Efficacy of vaccination with recombinant vaccinia and fowlpox vectors expressing NY-ESO-1 antigen in ovarian cancer and melanoma patients.
|
|
Academic Article
|
Mature neutrophils suppress T cell immunity in ovarian cancer microenvironment.
|
|
Academic Article
|
A harmonized approach to intracellular cytokine staining gating: Results from an international multiconsortia proficiency panel conducted by the Cancer Immunotherapy Consortium (CIC/CRI).
|
|
Academic Article
|
Successful elimination of memory-type CD8+ T cell subsets by the administration of anti-Gr-1 monoclonal antibody in vivo.
|
|
Academic Article
|
Stimulation of an anti-tumor immune response with "chromatin-damaging" therapy.
|
|
Academic Article
|
NY-ESO-1 expression predicts an aggressive phenotype of ovarian cancer.
|
|
Academic Article
|
Unexpected role of TNF-alpha in graft versus host reaction (GVHR): donor-derived TNF-alpha suppresses GVHR via inhibition of IFN-gamma-dependent donor type-1 immunity.
|
|
Academic Article
|
CXCR3+ T regulatory cells selectively accumulate in human ovarian carcinomas to limit type I immunity.
|
|
Academic Article
|
Tumor-infiltrating NY-ESO-1-specific CD8+ T cells are negatively regulated by LAG-3 and PD-1 in human ovarian cancer.
|
|
Academic Article
|
GEN-1 in Combination with Neoadjuvant Chemotherapy for Patients with Advanced Epithelial Ovarian Cancer: A Phase I Dose-escalation Study.
|
|
Academic Article
|
CXCR6 by increasing retention of memory CD8+ T cells in the ovarian tumor microenvironment promotes immunosurveillance and control of ovarian cancer.
|
|
Academic Article
|
Identification of Claudin 6-specific HLA class I- and HLA class II-restricted T cell receptors for cellular immunotherapy in ovarian cancer.
|
|
Academic Article
|
Recombinant human Hsp110-gp100 chaperone complex vaccine is nontoxic and induces response in advanced stage melanoma patients.
|
|
Academic Article
|
Metabolic adaptation of ovarian tumors in patients treated with an IDO1 inhibitor constrains antitumor immune responses.
|
|
Academic Article
|
Implanted tumor growth is suppressed and survival is prolonged in sixty percent of food-restricted mice.
|
|
Academic Article
|
Tcf-1 protects anti-tumor TCR-engineered CD8+ T-cells from GzmB mediated self-destruction.
|
|
Academic Article
|
Tissue residency of memory CD8+ T cells matters in shaping immunogenicity of ovarian cancer.
|
|
Academic Article
|
Correction to: Tcf-1 protects anti-tumor TCR-engineered CD8+ T-cells from GzmB mediated self-destruction.
|
|
Academic Article
|
Loss-of-function of the hippo transducer TAZ reduces mammary tumor growth through a myeloid-derived suppressor cell-dependent mechanism.
|
|
Concept
|
Triple Negative Breast Neoplasms
|
|
Concept
|
Cell- and Tissue-Based Therapy
|
|
Concept
|
In Vitro Techniques
|
|
Academic Article
|
Galectin-3 expression in donor T cells reduces GvHD severity and lethality after allogeneic hematopoietic cell transplantation.
|
|
Academic Article
|
Predictive and Prognostic Implications of Circulating CX3CR1+ CD8+ T Cells in Non-Small Cell Lung Cancer Patients Treated with Chemo-Immunotherapy.
|
|
Academic Article
|
NK Receptors Replace CD28 As the Dominant Source of Signal 2 for Cognate Recognition of Cancer Cells by TAA-specific Effector CD8+ T Cells.
|
|
Academic Article
|
Trans-vaccenic acid reprograms CD8+ T cells and anti-tumour immunity.
|